tiprankstipranks
Trending News
More News >
Salarius Pharmaceuticals Inc (SLRX)
NASDAQ:SLRX
US Market

Salarius Pharmaceuticals (SLRX) Income Statement

Compare
624 Followers

Salarius Pharmaceuticals Income Statement

Last quarter (Q3 2025), Salarius Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Salarius Pharmaceuticals's net income was $-873.47K. See Salarius Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 5.23M
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 5.23M
Operating Expenses
$ 5.73M$ 12.89M$ 31.84M$ 12.81M$ 13.02M
Depreciation and Amortization
$ 4.42K$ 10.05K$ 6.68K$ 19.18K$ 18.06K
EBITDA
$ -5.73M$ -12.88M$ -22.97M$ -12.79M$ -7.59M
Operating Income
$ -5.73M$ -12.89M$ -31.84M$ -12.81M$ -7.79M
Other Income/Expenses
$ 158.54K$ 352.25K$ 233.18K$ 44.69K$ 434.09K
Pretax Income
$ -5.58M$ -12.54M$ -31.61M$ -12.77M$ -7.35M
Net Income
$ -5.58M$ -12.54M$ -31.61M$ -12.77M$ -7.35M
Per Share Metrics
Basic EPS
$ -86.85$ -0.06$ -221.55$ -930.00$ -1.50K
Diluted EPS
$ -86.85$ -0.06$ -221.55$ -930.00$ -1.50K
Weighted Average Shares Outstanding
--- 13.80K-
Weighted Average Shares Outstanding (Diluted)
-----
Currency in USD

Salarius Pharmaceuticals Earnings and Revenue History